Late in-stent restenosis in coronary arteries and in grafts by DEBBAS, N. M. G. et al.
528 Letters to the Editor
Figure 1 Excised mitral valve specimen. View is from the
atrial side. Note the large tear in the posterolateral leaflet
111.
commissures has been documented to
be the mechanism by which mitral
valve area increases following balloon
valvuloplasty. This same mechanism is
responsible for mild increases in mitral
regurgitation141.
Outcome following balloon
valvuloplasty has been related to the
BVR score'31. Only one study has been
able to demonstrate a correlation
between valvular morphology and the
development of mitral regurgitation151.
From an echocardiographic point
of view the patient described had a
favourable valve for mitral com-
missurotomy. The severe mitral regur-
gitation that resulted was due to
non-commissural tearing of the pos-
terolateral leaflet. This complication
is in keeping with the findings of
Essop'41, who speculates that 'ex-
cessively pliable valves may constitute
a risk factor for leaflet rupture and
abrupt mitral regurgitation'. Though
outcome was better for patients with
a lower BVR score in the NHLBI
study131, valve morphology did not
predict the development of mitral
regurgitation in this or other studies'41.
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Late in-stent restenosis in coronary
arteries and in grafts
Intracoronary stents were at first
limited to the treatment of restenosis,
angioplasty-related acute coronary
closure and graft lesions. Their use has
greatly widened to include new onset
lesions in native vessels, following two
recent trials showing less restenosis in
patients treated with stents compared
to conventional angioplasty'1-21. No
long-term prospective data are avail-
able on stenting. One report suggests
that the time course of restenosis after
intracoronary stenting is similar to
that after conventional angioplasty131,
while another hypothesizes that stent-
ing may only be a mechanical way of
delaying restenosis process'41. Thus,
we reviewed the incidence of late
(defined as >6 months) in-stent
restenosis in our early series of 131
Wallstents implanted between 1986
and 1989.
We report on four male
patients aged 50 to 70 who underwent
conventional balloon angioplasty for
stenosis >50% measured by quanti-
tative coronary angiographic analysis.
Stents were implanted for restenosis in
one native right coronary artery, for
angioplasty-induced acute closure in
one venous graft and one native right
coronary artery, and for suboptimal
results after angioplasty in a venous
graft. A total of six self-expandable
Wallstents (Schneider AG, Zurich,
Switzerland) were implanted using the
standard technique'51. All patients
were treated with anticoagulation for
6 months and antiplatelet therapy. Six
months following the procedure, a
control coronary angiogram was per-
formed. From then onwards, repeat
angiograms were dictated by each
patient's individual clinical outcome.
Quantitative coronary angio-
graphic analysis was performed and
in-stent restenosis was defined as a
reduction of the vessel diameter to
< 50% located at the very same site as
the original lesion.
Clinically, patients remained
well during the first 6 months follow-
ing stent implantation. There was no
angiographic restenosis at 6 months
(Fig. 1, Table 1). In two patients,
further follow-up angiograms were
obtained. One patient complained
of increasing atypical chest pain
18 months after stent implantation
and a coronary angiogram showed no
changes in the coronary status, in par-
ticular there was no in-stent restenosis
(Table 1). The second patient devel-
oped recurrent angina 38 months after
stent implantation and underwent suc-
cessful coronary artery bypass surgery
for a proximal left anterior descending
artery lesion; there was no in-stent
restenosis (Fig. 1, Table 1).
All four patients presented
with recurrent angina pectoris 43 and
87 months after stent implantation
and late in-stent restenosis was diag-
nosed (Fig. 1, Tale 1). There was also
progression of coronary artery disease
(significant stenosis >50%) within the
same vessel in two patients.
These late restenosis were
successfully treated with conventional
balloon angioplasty in three patients
and with coronary artery bypass
grafting in one.
Following intracoronary stent-
ing. as after conventional angioplasty,
a 6-month period is considered to be
critical for restenosis. Its rate varies
between 20 and 40% depending on
many factors such as definition of
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Figure 1 Angiographic images of
the right coronary artery in patient
1: (a) stenosis before stent implan-
tation; (b) immediate result after
stenting; (c) 6 months follow-up
angiogram showing no in-stent
re-stenosis; (d) in-stent restenosis
7 years and 3 months after implan-
tation; (e) immediate result
after in-stent conventional balloon
angioplasty.
Table 1 Angiographic data in four patients developing very late re-stenosis
within Wallstents
Indication for stenting
Stent diameter
Vessel
Reference diameter
Implantation
MLD-pre
MLD-post
% stenosis-pre
% stenosis-post
6 months follow-up
MLD
% stenosis
Further follow-up
MLD
% stenosis
acute closure
3-5 mm
RCA
3-5 mm
0 6 mm
30 mm
83%
9%
3-2 mm
10%
(38 months)
2-2 mm
37%
Late restenosis and in-stent dilatation
time 87 months
MLD-pre 0-6 mm
MLD-post 2-6 mm
% stenosis-pre
% stenosis-post
81%
21%
acute closure
4-5 mm
venous graft
4-7 mm
11 mm
3-5 mm
75%
29%
2-6 mm
35%
—
60 months
0-8 mm
3-6 mm
79%
20%
restenosis
40 mm
RCA
3-4 mm
11 mm
2-4 mm
79%
32%
1-9 mm
46%
(18 months)
1-7 mm
46%
69 months
1-5 mm
grafted
69%
de novo
4-0 mm
venous graft
3-2 mm
0 6 mm
2-6 mm
71%
7%
2-4mm
23%
—
43 months
0-7 mm
2 6 mm
75%
20%
RCA = right coronary artery; MLD = mean lumen diameter; pre = before procedure;
post = after procedure.
restenosis, indication for stenting,
cohort of patients, anticoagulation
regimen etc. Assessment of coronary
lumen dimension demonstrates peak
changes at 3 months and, in most
cases, remains stable after 6 months'31.
Restenosis is believed to be very
rare later'1"31. However, some isolated
reports suggest that in-stent re-stenosis
can occur late'6', particularly in grafts.
The theory that stenting, through
its double action of creating a larger
immediate vessel diameter and of
inhibiting elastic recoil, may only be a
way of delaying intimal hyperplasia —
the characteristic feature of restenosis —
as opposed to avoiding it, has also
recently been put forward'41.
In our series of 131 Wallstents
implanted in 105 patients, 100%
6-months clinical and angiographic
follow-up was obtained. At late
follow-up 89 (range 55 to 104) months
after stenting, 20 (19%) patients
(including four non-cardiac deaths)
were lost to follow-up, and clinical
follow-up was obtained on the 85
(81%) remaining patients. There were
9 (9%) stent related deaths. Eight
patients (8%) had had a subacute
thrombosis and 15 (14%), a restenosis
at 6 months. Of the 53 remaining
patients, 34 (representing 64% of the
eligible patients), including the four
patients reported here, underwent a
late angiogram. This control was re-
fused by the other 19 patients or their
referring doctors, because of lack
of symptoms. Hence in our group of
105 patients, four symptomatic late
in-stent restenoses have occurred,
amounting to 4% of the initial group.
Because of the long delay
between stenting and restenosis, cor-
onary artery disease progression could
be advocated as opposed to true re-
stenosis. Great care was taken to en-
sure that restenosis was located at the
site originally dilated. Moreover, pro-
gression of coronary artery disease
was noted in two of the four cases
outside the stent and was treated as
separate lesions.
One potential explanation for
these very late in-stent restenoses
would be a reaction to stent breakage
due to shear wear and tear over
years. However this remains pure
speculation as we do not have any
pathology specimen.
In conclusion, very late-in-
stent restenosis has to be expected. It is
encouraging to estimate its incidence
at a low figure, probably comparable
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to that after conventional balloon
angioplasty.
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The mechanism of catecholaminergic
polymorphic ventricular tachycardia
may be triggered activity due to
delayed afterdepolarization
Bi-directional or polymorphic ven-
tricular tachycardia (VT) is an uncom-
mon disorder whose aetiology and
mechanism is unknown. There are a
few reports on patients with bidirec-
tional or polymorphic VT in the
absence of structural heart disease.
Among them, Leenhardt et al. have
reported cases of catecholaminergic
polymorphic VT[1).
We also had a case of cat-
echolaminergic polymorphic VT. A
14-year-old Japanese male was
referred to us for the evaluation of
ventricular tachyarrhythmias. Since
the age of 5 years, he had experienced
several episodes of syncope due to
ventricular tachyarrhythmia associ-
ated with exercise or an increase in
physical activity. His family history
revealed no evidence of syncope or of
sudden death. Physical examination
revealed a slow pulse rate, and a car-
diac pansystolic murmur (Levein 2/6)
was audible at the apex of the heart.
Results of biochemical tests were nor-
mal. The resting 12-lead ECG showed
sinus bradycardia with a rate of 42
beats, min"1, a normal QT interval
with QTc 0-41 s. Chest X-rays showed
a cardiothoracic index of 0-48.
Echocardiography revealed mild
mitral valve regurgitation, but good
ventricular function. Cardiac cath-
eterization revealed normal coronary
arteries. Despite the presence of mild
mitral valve regurgitation, we were
convinced that structural heart disease
was absent. In this case, bidirectional
or polymorphic VT was reproducibly
induced by humoral (exercise, iso-
proterenol injection) or neurogenic
(stress, emotion) sympathetic stimu-
Figure 1 (a) Twelve-lead electrocardiogram during bidirectional VT. There is an
alternating pattern of right and left bundle branch block (R/LBBB), or an
alternating left and right axis deviation with an RBBB or LBBB pattern. Thus,
QRS pattern varied, (b) Recordings of MAP at right ventricular inflow. After
bidirectional VT induced spontaneously by emotion disappeared, humps are
observed during phase 4 (arrows) (c) During the infusion of isoproterenol, the
humps gradually increased (arrows), (d) After the injection of propranolol, the
humps gradually reduced and finally disappeared.
Eur Heart J, Vol. 18, March 1997
